1
Enquiry period
with 06.02.2024 16:20
to 09.02.2024 15:00
2
Bidding period
with 09.02.2024 15:00
to 12.02.2024 15:30
3
Auction

4
Evaluation
5
Bids have been evaluated
Status Bids have been evaluated
Estimated value without VAT 3 000 MDL
Period of clarifications: 6 Feb 2024, 16:20 - 9 Feb 2024, 15:00
Submission of proposals: 9 Feb 2024, 15:00 - 12 Feb 2024, 15:30
Auction start date: will not be used

Supplier technical support:

(+373) 79999801


This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.

Test-card Hbcore
Information about customer
Fiscal code/IDNO
Address
Md 5600, MOLDOVA, Rîşcani, or.Rîşcani, str,N.Testemițeanu 6
Web site
---
The contact person
Full name
tozlovanu sergiu
Contact phone
069007208
Purchase data
Date created
30 Jan 2024, 11:46
Date modified
6 Feb 2024, 16:20
Estimated value (without VAT)
3 000 MDL
Achizitii.md ID
21162115
Type of procedure
Low cost purchase
Award criteria
The lowest price
Delivery address
Md 5600, MOLDOVA, Rîşcani, or.Rîşcani, str,N.Testemițeanu 6
Contract period
14 Feb 2024 15:48 - 30 Dec 2024 16:20
List of positions
1)
Title
Test-card Hbcore CPV: 33600000-6 - Pharmaceutical products
Quantity: 250.0
Unit of measurement: Bucata
Documents of the procurement procedure
Qualification
Participant(s) name(s)
Normalized price
Status
1
Participant(s) name(s):

Sanmedico

Normalized price: 2 662,50 MDL
Status: Winner
Reason: oferta întrunește condițiile de calificare
Qualification documents
Documents provided with the proposal
2
Participant(s) name(s):

Profilabdiagnostic SRL

Normalized price: 8 250 MDL
Status: Awaiting

Documents such as "Qualification Documentation", "financial proposal" and "Illustration" will be browseable for all only after your offer has been placed in "pending" status.

Reason: Not indicated
Qualification documents
Documents folder missing
Documents provided with the proposal
The history of the auction
View auction
Unfortunately, questions can be asked only during the "Active" period.
Clarifications